Q32 Bio (QTTB) Revenue (2018 - 2023)
Q32 Bio (QTTB) posted quarterly Revenue of -$1.4 million for Q4 2023, down 269.58% year-over-year from $802000.0 in Q4 2022, and down 173.16% quarter-over-quarter from $1.9 million in Q3 2023.
Q32 Bio (QTTB) Revenue (2018 - 2023) Analysis & Trends
Q32 Bio's Revenue history runs 6 years deep, the most recent figure standing at -$1.4 million for Q4 2023.
- In Q4 2023, Revenue fell 269.58% year-over-year to -$1.4 million; the TTM figure through Sep 2024 stood at -$1.4 million (down 115.43% YoY), while the FY2025 annual figure was $53.7 million, changed N/A from the prior year.
- Revenue for Q4 2023 stood at -$1.4 million, down from $1.9 million in the prior quarter.
- The five-year high for Revenue was $29.3 million in Q1 2021, with the low at -$1.4 million in Q4 2023.
- The 5-year median for Revenue is $802000.0 (2021), against an average of $2.4 million.
- The sharpest annual moves came in 2021 and 2023: Revenue soared 4883.84% in 2021, then sank 269.58% in 2023.
- Q32 Bio's Revenue stood at $563000.0 in 2019, then surged by 74.07% to $980000.0 in 2020, then slipped by 18.16% to $802000.0 in 2021, then changed by 0.0% to $802000.0 in 2022, then tumbled by 269.58% to -$1.4 million in 2023.
- Business Quant data shows QTTB's Revenue at -$1.4 million in Q4 2023, $1.9 million in Q3 2023, and $3.2 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Q32 Bio | 359.61 Mn | 253.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1.36 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 3.21 Mn |
| Mar 31, 2023 | 2.95 Mn |
| Dec 31, 2022 | 802,000.00 |
| Sep 30, 2022 | 802,000.00 |
| Jun 30, 2022 | 802,000.00 |
| Mar 31, 2022 | 802,000.00 |
| Dec 31, 2021 | 802,000.00 |
| Sep 30, 2021 | 1.68 Mn |
| Jun 30, 2021 | 2.19 Mn |
| Mar 31, 2021 | 29.31 Mn |
| Dec 31, 2020 | 980,000.00 |
| Sep 30, 2020 | 567,000.00 |
| Jun 30, 2020 | 567,000.00 |
| Mar 31, 2020 | 588,000.00 |
| Dec 31, 2019 | 563,000.00 |
| Sep 30, 2019 | 441,000.00 |
| Jun 30, 2019 | 392,000.00 |
| Mar 31, 2019 | 270,000.00 |